Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Yufang Wang, Qiang Zhou, Hao Dai, Tao Zhang & Dong-Qing Wei. (2012) Prediction of the functional consequences of single amino acid substitution in human cytochrome P450. Molecular Simulation 38:14-15, pages 1297-1307.
Read now
Read now
Prajwal P Nandekar & Abhay T Sangamwar. (2012) Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings. Expert Opinion on Drug Discovery 7:9, pages 771-789.
Read now
Read now
J. Gonzalez, N. Marchand-Geneste, J.L. Giraudel & T. Shimada. (2012) Docking and QSAR comparative studies of polycyclic aromatic hydrocarbons and other procarcinogen interactions with cytochromes P450 1A1 and 1B1. SAR and QSAR in Environmental Research 23:1-2, pages 87-109.
Read now
Read now
E.D. Bruce, R.L. Autenrieth, R.C. Burghardt, K.C. Donnelly & T.J. McDonald. (2009) Modeling toxic endpoints for improving human health risk assessment of polycyclic aromatic hydrocarbons – parent compounds and simple mixtures. Toxicological & Environmental Chemistry 91:1, pages 137-156.
Read now
Read now
EricaD. Bruce, RobinL. Autenrieth, RobertC. Burghardt, K. C. Donnelly & ThomasJ. McDonald. (2008) Using Quantitative Structure–Activity Relationships (QSAR) to Predict Toxic Endpoints for Polycyclic Aromatic Hydrocarbons (PAH). Journal of Toxicology and Environmental Health, Part A 71:16, pages 1073-1084.
Read now
Read now
Alfred G. Hildebrandt, Dieter Schwarz, Solveigh Krusekopf, Ullrich Kleeberg & Ivar Roots. (2007) Recalling P446. P4501A1 (CYP1A1) Opting for Clinical Application. Drug Metabolism Reviews 39:2-3, pages 323-341.
Read now
Read now
SpencerS. Ericksen & GrazynaD. Szklarz. (2005) Regiospecificity of Human Cytochrome P450 1A1-Mediated Oxidations: The Role of Steric Effects. Journal of Biomolecular Structure and Dynamics 23:3, pages 243-256.
Read now
Read now
David S. Wishart. (2005) Bioinformatics in Drug Development and Assessment. Drug Metabolism Reviews 37:2, pages 279-310.
Read now
Read now
RUTE DA FONSECA, MARIA
CRISTINA MENZIANI, ANDRÉ MELO & MARIA
JOÃO RAMOS. (2003) Modelling the metabolic action of human and rat CYP1A2 and its relationship with the carcinogenicity of heterocyclic amines. Molecular Physics 101:17, pages 2731-2741.
Read now
Read now
Articles from other publishers (36)
Arthur G. Roberts, Jeffrey C. Stevens, Grazyna D. Szklarz, Emily E. Scott, Santosh Kumar, Manish B. Shah & James R. Halpert. (2023) Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond. Drug Metabolism and Disposition 51:1, pages 111-122.
Crossref
Crossref
Rana Adnan Tahir, Farwa Hassan, Abdul Kareem, Umer Iftikhar & Sheikh Arslan Sehgal. (2020) Ligand-Based Pharmacophore Modeling and Virtual Screening to Discover Novel CYP1A1 Inhibitors. Current Topics in Medicinal Chemistry 19:30, pages 2782-2794.
Crossref
Crossref
Hongjoo Ha, Kapsong Park, Guyoung Kang & Sungjong Lee. (2019) QSAR study using acute toxicity of Daphnia magna and Hyalella azteca through exposure to polycyclic aromatic hydrocarbons (PAHs). Ecotoxicology 28:3, pages 333-342.
Crossref
Crossref
Zbigniew Dutkiewicz & Renata Mikstacka. (2018) Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors. Bioinorganic Chemistry and Applications 2018, pages 1-21.
Crossref
Crossref
Lu Huo, Jingbao Liu, M. Denise Dearing, Grazyna D. Szklarz, James R. Halpert & P. Ross Wilderman. (2017)
Rational Re-Engineering of the O-Dealkylation of 7-Alkoxycoumarin Derivatives by Cytochromes P450 2B from the Desert Woodrat
Neotoma lepida
. Biochemistry 56:16, pages 2238-2246.
Crossref
Crossref
Rebeca Santes-Palacios, Antonio Romo-Mancillas, Rafael Camacho-Carranza & Jesús Javier Espinosa-Aguirre. (2016) Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds. Toxicology Letters 258, pages 267-275.
Crossref
Crossref
Prajwal P. Nandekar, Kailas Khomane, Vikas Chaudhary, Vijay P. Rathod, Roshan M. Borkar, Murali Mohan Bhandi, R. Srinivas, Abhay T. Sangamwar, Sankar K. Guchhait & Arvind K. Bansal. (2016) Identification of leads for antiproliferative activity on MDA-MB-435 human breast cancer cells through pharmacophore and CYP1A1-mediated metabolism. European Journal of Medicinal Chemistry 115, pages 82-93.
Crossref
Crossref
Manish B. Shah, Jingbao Liu, Lu Huo, Qinghai Zhang, M. Denise Dearing, P. Ross Wilderman, Grazyna D. Szklarz, C. David Stout & James R. Halpert. (2016) Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives as Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism. Molecular Pharmacology 89:4, pages 435-445.
Crossref
Crossref
Rong Li, Bianca Perez, Hui Jian, Mads Mørk Jensen, Renjun Gao, Mingdong Dong, Marianne Glasius & Zheng Guo. (2015) Characterization and mechanism insight of accelerated catalytic promiscuity of Sulfolobus tokodaii (ST0779) peptidase for aldol addition reaction. Applied Microbiology and Biotechnology 99:22, pages 9625-9634.
Crossref
Crossref
Tomohide Uno, Chiho Izumi, Shinji Takenaka, Takeshi Yanase, Hiromasa Imaishi, Kengo Kanamaru, Hiroshi Yamagata, Yoshio Kaminishi & Takao Itakura. (2015) Functional characterization of CYP1A9 and CYP1C1 from Anguillus japonica. Environmental Toxicology and Pharmacology 40:2, pages 360-368.
Crossref
Crossref
Anuradha Roy, Gerald H. Lushington, James McGee & Rathnam Chaguturu. 2013. Enzyme Technologies. Enzyme Technologies
1
53
.
Agnes A. Walsh, Grazyna D. Szklarz & Emily E. Scott. (2013) Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism. Journal of Biological Chemistry 288:18, pages 12932-12943.
Crossref
Crossref
Jürgen Pleiss. 2012. Enzyme Catalysis in Organic Synthesis. Enzyme Catalysis in Organic Synthesis
89
117
.
Youbin Tu. (2012) Exploring structurally conservative blocks as universal templates for modeling eukaryotic cytochrome P450s. Drug Metabolism and Drug Interactions 27:4.
Crossref
Crossref
Qiang Zheng, Xianyi Sha, Jiansheng Liu, Elisabeth Heath, Patricia LoRusso & Jing Li. (2010)
Association of Human Cytochrome P450 1A1 (
CYP1A1
) and Sulfotransferase 1A1 (
SULT1A1
) Polymorphisms with Differential Metabolism and Cytotoxicity of Aminoflavone
. Molecular Cancer Therapeutics 9:10, pages 2803-2813.
Crossref
Crossref
Jie Pan, Gen-Yan Liu, Jin Cheng, Xin-Jie Chen & Xiu-Lian Ju. (2010) CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450 1A1 inhibitors. European Journal of Medicinal Chemistry 45:3, pages 967-972.
Crossref
Crossref
Parminder K. Mankoo, Saraswati Sukumar & Rachel Karchin. (2009) PIK3CA somatic mutations in breast cancer: Mechanistic insights from Langevin dynamics simulations. Proteins: Structure, Function, and Bioinformatics 75:2, pages 499-508.
Crossref
Crossref
Youbin Tu, Rahul Deshmukh, Meena Sivaneri & Grazyna D. Szklarz. (2008) Application of Molecular Modeling for Prediction of Substrate Specificity in Cytochrome P450 1A2 Mutants. Drug Metabolism and Disposition 36:11, pages 2371-2380.
Crossref
Crossref
Matthew G. Hudelson, Nikhil S. Ketkar, Lawrence B. Holder, Timothy J. Carlson, Chi-Chi Peng, Benjamin J. Waldher & Jeffrey P. Jones. (2008) High Confidence Predictions of Drug−Drug Interactions: Predicting Affinities for Cytochrome P450 2C9 with Multiple Computational Methods. Journal of Medicinal Chemistry 51:3, pages 648-654.
Crossref
Crossref
B.C. Lewis, P.I. Mackenzie & J.O. Miners. (2007) Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis. Archives of Biochemistry and Biophysics 468:1, pages 58-69.
Crossref
Crossref
Chris de Graaf, Chris Oostenbrink, Peter H. J. Keizers, Barbara M. A. van Vugt-Lussenburg, Jan N. M. Commandeur & Nico P. E. Vermeulen. (2007) Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations. European Biophysics Journal 36:6, pages 589-599.
Crossref
Crossref
Jahnavi C. Prasad, Jared V. Goldstone, Carlos J. Camacho, Sandor Vajda & John J. Stegeman. (2007)
Ensemble Modeling of Substrate Binding to Cytochromes P450: Analysis of Catalytic Differences between CYP1A Orthologs
,
. Biochemistry 46:10, pages 2640-2654.
Crossref
Crossref
Valérie Taly, Philippe Urban, Gilles Truan & Denis Pompon. (2007) A combinatorial approach to substrate discrimination in the P450 CYP1A subfamily. Biochimica et Biophysica Acta (BBA) - General Subjects 1770:3, pages 446-457.
Crossref
Crossref
Dieter Schwarz, Pyotr Kisselev, Alexey Chernogolov, Wolf-Hagen Schunck & Ivar Roots. (2005) Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns. Biochemical and Biophysical Research Communications 336:3, pages 779-783.
Crossref
Crossref
F. Iori, R. da Fonseca, M. João Ramos & M.C. Menziani. (2005) Theoretical quantitative structure–activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes. Bioorganic & Medicinal Chemistry 13:14, pages 4366-4374.
Crossref
Crossref
Ilia G. Denisov, Thomas M. Makris, Stephen G. Sligar & Ilme Schlichting. (2005) Structure and Chemistry of Cytochrome P450. Chemical Reviews 105:6, pages 2253-2278.
Crossref
Crossref
Yuet-Kin Leung, Kin-Mang Lau, James Mobley, Zhong Jiang & Shuk-Mei Ho. (2005)
Overexpression of
Cytochrome P450 1A1
and Its Novel Spliced Variant in Ovarian Cancer Cells: Alternative Subcellular Enzyme Compartmentation May Contribute to Carcinogenesis
. Cancer Research 65:9, pages 3726-3734.
Crossref
Crossref
Shankar J. Chinta, Reddy P. Kommaddi, Cheri M. Turman, Henry W. Strobel & Vijayalakshmi Ravindranath. (2005)
Constitutive expression and localization of cytochrome P‐450 1A1 in rat and human brain: presence of a splice variant form in human brain
1
. Journal of Neurochemistry 93:3, pages 724-736.
Crossref
Crossref
Pyotr Kisselev, Wolf-Hagen Schunck, Ivar Roots & Dieter Schwarz. (2005) Association of CYP1A1 Polymorphisms with Differential Metabolic Activation of 17β-Estradiol and Estrone. Cancer Research 65:7, pages 2972-2978.
Crossref
Crossref
Chris de Graaf, Nico P. E. Vermeulen & K. Anton Feenstra. (2005) Cytochrome P450 in Silico: An Integrative Modeling Approach. Journal of Medicinal Chemistry 48:8, pages 2725-2755.
Crossref
Crossref
Dieter Schwarz, Pyotr Kisselev & Ivar Roots. (2005) CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. European Journal of Cancer 41:1, pages 151-158.
Crossref
Crossref
Carol A. Kemp, Jean-Didier Maréchal & Michael J. Sutcliffe. (2005) Progress in cytochrome P450 active site modeling. Archives of Biochemistry and Biophysics 433:2, pages 361-368.
Crossref
Crossref
Konstantin V. Balakin, Sean Ekins, Andrey Bugrim, Yan A. Ivanenkov, Dmitry Korolev, Yuri V. Nikolsky, Andrey V. Skorenko, Andrey A. Ivashchenko, Nikolay P. Savchuk & Tatiana Nikolskaya. (2004) KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4. Drug Metabolism and Disposition 32:10, pages 1183-1189.
Crossref
Crossref
Dieter Schwarz, Pyotr Kisselev, Spencer S Ericksen, Grazyna D Szklarz, Alexey Chernogolov, Horst Honeck, Wolf-Hagen Schunck & Ivar Roots. (2004) Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochemical Pharmacology 67:8, pages 1445-1457.
Crossref
Crossref
Jianguo Liu, Spencer S Ericksen, Meena Sivaneri, Dan Besspiata, Charles W Fisher & Grazyna D Szklarz. (2004) The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism. Archives of Biochemistry and Biophysics 424:1, pages 33-43.
Crossref
Crossref
Jianguo Liu, Spencer S. Ericksen, Dan Besspiata, Charles W. Fisher & Grazyna D. Szklarz. (2003) Characterization of Substrate Binding to Cytochrome P450 1A1 Using Molecular Modeling and Kinetic Analyses: Case of Residue 382. Drug Metabolism and Disposition 31:4, pages 412-420.
Crossref
Crossref